Do mutator mutations fuel tumorigenesis?

Area of Science:

• Oncology
• Genetics
• Cancer Biology

Background:

• The mutator phenotype hypothesis posits that elevated mutation rates in cancer cells drive tumor evolution.
• Human cancers display a high mutation burden, suggesting a rate higher than normal cells.

Purpose of the Study:

• To review evidence for and against the mutator phenotype hypothesis.
• To discuss the clinical implications of increased mutation rates in tumors.
• To propose alternative cancer therapeutic strategies.

Main Methods:

• Review of recent evidence supporting the mutator phenotype hypothesis.
• Analysis of arguments against the mutator phenotype concept.
• Discussion of clinical consequences and therapeutic possibilities.

Main Results:

• Tumors are predicted to comprise heterogeneous cell populations with numerous mutations.
• Pre-existing drug-resistant cells are likely present in diverse tumors.
• Targeting specific driver mutations may have limited efficacy.

Conclusions:

• Reconsideration of current personalized cancer therapy approaches is necessary.
• Targeting pathways that modulate mutation accumulation rates shows therapeutic promise.
• Altering tumor mutation rates may be more effective than targeting individual genes.